The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity

被引:26
作者
Rinaldi, Roberta [1 ]
De Nucci, Sara [1 ]
Castellana, Fabio [2 ]
Di Chito, Martina [1 ]
Giannuzzi, Vito [3 ]
Shahini, Endrit [3 ]
Zupo, Roberta [2 ]
Lampignano, Luisa [2 ]
Piazzolla, Giuseppina [4 ]
Triggiani, Vincenzo [4 ]
Cozzolongo, Raffaele [3 ]
Giannelli, Gianluigi [5 ]
De Pergola, Giovanni [1 ]
机构
[1] IRCCS Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Geriatr & Internal Med, I-70013 Castellana Grotte, Bari, Italy
[2] IRCCS Hosp, Natl Inst Gastroenterol Saverio Bellis, Unit Data Sci & Technol Innovat Populat Hlth, I-70013 Castellana Grotte, Bari, Italy
[3] IRCCS Hosp, Natl Inst Gastroenterol Saverio Bellis, Dept Gastroenterol, I-70013 Castellana Grotte, Bari, Italy
[4] Univ Bari Aldo Moro, Sch Med, Interdisciplinary Dept Med, Piazza Giulio Cesare 11, I-70124 Bari, Italy
[5] IRCCS Hosp, Natl Inst Gastroenterol Saverio Bellis, Sci Direct, I-70013 Castellana Grotte, Bari, Italy
关键词
non-alcoholic fatty liver disease (NAFLD); very low calorie ketogenic diet (VLCKD); obesity; insulin resistance; transient elastography (FibroScan); DISEASE; MANAGEMENT; GUIDELINES; STEATOSIS;
D O I
10.3390/nu15040825
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Very low-calorie ketogenic diets (VLCKD) are widely employed in successful weight-loss strategies. Herein, we evaluated the efficacy and safety of a VLCKD on non-alcoholic fatty liver disease (NAFLD) and parameters commonly associated with this condition in overweight and obese subjects who did not take any drugs. This prospective, real-life study included thirty-three participants who followed a VLCKD for 8 weeks. NAFLD was diagnosed using transient elastography (FibroScan). Data on anthropometric measurements, bioimpedance analysis, and biochemical assays were gathered both before and after the dietary intervention. BMI (kg/m(2)) (from 33.84 +/- 6.55 to 30.89 +/- 6.38, p < 0.01), waist circumference (cm) (from 106.67 +/- 15.51 to 98.64 +/- 16.21, p < 0.01), and fat mass (Kg) (from 38.47 +/- 12.59 to 30.98 +/- 12.39, p < 0.01) were significantly lower after VLCKD. CAP (db/m), the FibroScan parameter quantifying fatty liver accumulation, showed a significant reduction after VLCKD (from 266.61 +/- 67.96 to 223 +/- 64.19, p < 0.01). After VLCKD, the fatty liver index (FLI), a benchmark of steatosis, also revealed a significant decline (from 62.82 +/- 27.46 to 44.09 +/- 31.24, p < 0.01). Moreover, fasting blood glucose, insulin, triglycerides, total cholesterol, LDL-cholesterol, ALT, gamma GT, and FT3 blood concentrations, as well as insulin resistance (quantified by HOMAIR) and systolic and diastolic blood pressure levels, were significantly lower after VLCKD (p < 0.01 for all the parameters). By contrast, HDL-cholesterol, 25 (OH) vitamin D, and FT4 blood concentrations were higher after VLCKD (p < 0.01 for all parameters). The variation (delta) of CAP after VLCKD did not show a correlation with the delta of any other parameter investigated in this study. We conclude that VLCKD is a helpful approach for NAFLD independent of changes in factors commonly associated with NAFLD (obesity, fat mass, insulin resistance, lipids, and blood pressure) as well as vitamin D and thyroid hormone levels.
引用
收藏
页数:11
相关论文
共 37 条
  • [1] Adherence to the Mediterranean diet and risk of metabolic syndrome and its components
    Babio, N.
    Bullo, M.
    Basora, J.
    Martinez-Gonzalez, M. A.
    Fernandez-Ballart, J.
    Marquez-Sandoval, F.
    Molina, C.
    Salas-Salvado, J.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 563 - 570
  • [2] VLCKD: a real time safety study in obesity
    Barrea, Luigi
    Verde, Ludovica
    Vetrani, Claudia
    Marino, Francesca
    Aprano, Sara
    Savastano, Silvia
    Colao, Annamaria
    Muscogiuri, Giovanna
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [3] Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review
    Beaudart, Charlotte
    Bruyere, Olivier
    Geerinck, Anton
    Hajaoui, Manon
    Scafoglieri, Aldo
    Perkisas, Stany
    Bautmans, Ivan
    Gielen, Evelien
    Reginster, Jean-Yves
    Buckinx, Fanny
    [J]. CLINICAL NUTRITION ESPEN, 2020, 35 : 47 - 62
  • [4] The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
    Bedogni, Giorgio
    Bellentani, Stefano
    Miglioli, Lucia
    Masutti, Flora
    Passalacqua, Marilena
    Castiglione, Anna
    Tiribelli, Claudio
    [J]. BMC GASTROENTEROLOGY, 2006, 6 (1)
  • [5] Non-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography
    Berzigotti, Annalisa
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 170 - 177
  • [6] Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients with Obesity and Mild Kidney Failure
    Bruci, Adriano
    Tuccinardi, Dario
    Tozzi, Rossella
    Balena, Angela
    Santucci, Silvia
    Frontani, Riccardo
    Mariani, Stefania
    Basciani, Sabrina
    Spera, Giovanni
    Gnessi, Lucio
    Lubrano, Carla
    Watanabe, Mikiko
    [J]. NUTRIENTS, 2020, 12 (02)
  • [7] Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
    Caprio, M.
    Infante, M.
    Moriconi, E.
    Armani, A.
    Fabbri, A.
    Mantovani, G.
    Mariani, S.
    Lubrano, C.
    Poggiogalle, E.
    Migliaccio, S.
    Donini, L. M.
    Basciani, S.
    Cignarelli, A.
    Conte, E.
    Ceccarini, G.
    Bogazzi, F.
    Cimino, L.
    Condorelli, R. A.
    La Vignera, S.
    Calogero, A. E.
    Gambineri, A.
    Vignozzi, L.
    Prodam, F.
    Aimaretti, G.
    Linsalata, G.
    Buralli, S.
    Monzani, F.
    Aversa, A.
    Vettor, R.
    Santini, F.
    Vitti, P.
    Gnessi, L.
    Pagotto, U.
    Giorgino, F.
    Colao, A.
    Lenzi, A.
    Beccuti, Guglielmo
    Biondi, Bernadette
    Cannavo, Salvatore
    Chiodini, Iacopo
    De Feudis, Giuseppe
    Di Francesco, Simona
    Di Gregorio, Aldo
    Fallo, Francesco
    Foresta, Carlo
    Giacchetti, Gilberta
    Granata, Riccarda
    Isidori, Andrea M.
    Magni, Paolo
    Maiellaro, Pasquale
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (11) : 1365 - 1386
  • [8] Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
    Castellana, Marco
    Donghia, Rossella
    Guerra, Vito
    Procino, Filippo
    Lampignano, Luisa
    Castellana, Fabio
    Zupo, Roberta
    Sardone, Rodolfo
    De Pergola, Giovanni
    Romanelli, Francesco
    Trimboli, Pierpaolo
    Giannelli, Gianluigi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [9] Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
    Castera, Laurent
    Friedrich-Rust, Mireen
    Loomba, Rohit
    [J]. GASTROENTEROLOGY, 2019, 156 (05) : 1264 - +
  • [10] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357